Hepatocyte Steatosis Inhibits Hepatitis B Virus Secretion Via Induction of Endoplasmic Reticulum Stress

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2021 May 13

PMID 33983562

Citations 9

Authors

Qichuang Liu

Maoyuan Mu

Huan Chen

Guoyuan Zhang

Yanqing Yang

Jun Chu

Ying Li

Fangwan Yang

Shide Lin

Affiliations

Soon will be listed here.

Abstract

The effects of hepatocyte steatosis on hepatitis B virus (HBV) DNA replication and HBV-related antigen secretion are incompletely understood. The aims of this study are to explore the effects and mechanism of hepatocyte steatosis on HBV replication and secretion. Stearic acid (SA) and oleic acid (OA) were used to induce HepG2.2.15 cell steatosis in this study. The expressions of glucose-regulated protein 78 (GRP78), phosphorylation of protein kinase R-like endoplasmic reticulum (ER) kinase (p-PERK), and eukaryotic translation initiation factor 2α (p-eIF2α) were detected by Western blotting (WB). HBV DNA, HBsAg, and HBeAg in the supernatant were determined by real-time fluorescent polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay. Intracellular HBV DNA, HBsAg level, and HBV RNA were measured by real-time fluorescent PCR, WB, and real-time quantitative reverse transcriptase-PCR, respectively. The results showed that SA and OA significantly increased intracellular lipid droplets and triglyceride levels. SA and OA significantly induced GRP78, p-PERK, and p-eIF2α expressions from 24 to 72 h. 4-phenylbutyric acid (PBA) alleviated ER stress induced by SA. SA promoted intracellular HBsAg and HBV DNA accumulation; however, it inhibited the transcript of HBV 3.5 kb mRNA and S mRNA. The secretion of HBsAg and HBV DNA inhibited by SA or OA could be partially restored by pretreatment with PBA but not by inhibiting GRP78 expression with siRNA. Hepatocyte steatosis inhibits HBsAg and HBV DNA secretion via induction of ER stress in hepatocytes, but not via induction of GRP78.

Citing Articles

Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study.

Ren G, Jia K, Yin S, Guan Y, Cong Q, Zhu Y Virol J. 2025; 22(1):30.

PMID: 39920779 PMC: 11804069. DOI: 10.1186/s12985-025-02642-9.

Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction.

Majeed A, Butt A World J Hepatol. 2025; 17(1):100968.

PMID: 39871900 PMC: 11736482. DOI: 10.4254/wjh.v17.i1.100968.

Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD.

Liu C, Seto W, Yu M Hepatol Int. 2024; 18(Suppl 2):897-908.

PMID: 39115632 DOI: 10.1007/s12072-024-10699-x.

Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level.

Wu L, Li Z, Gao N, Deng H, Zhao Q, Hu Z Heliyon. 2024; 10(12):e32730.

PMID: 38975233 PMC: 11226829. DOI: 10.1016/j.heliyon.2024.e32730.

Response to the letter of HEPI-D-24-00252.

Huang S, Su T, Kao J Hepatol Int. 2024; 18(4):1340-1341.

PMID: 38922483 DOI: 10.1007/s12072-024-10681-7.

References

Sarin S, Kumar M, Eslam M, George J, Al Mahtab M, Akbar S . Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019; 5(2):167-228. PMC: 7164809. DOI: 10.1016/S2468-1253(19)30342-5. View

Zhang J, Lin S, Jiang D, Li M, Chen Y, Li J . Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?. Liver Int. 2020; 40(3):496-508. DOI: 10.1111/liv.14369. View

Wang L, Wang Y, Liu S, Zhai X, Zhou G, Lu F . Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population. J Gastroenterol. 2019; 54(12):1096-1105. DOI: 10.1007/s00535-019-01594-6. View

Hu D, Wang H, Wang H, Wang Y, Wan X, Yan W . Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model. Hepatol Int. 2018; 12(5):438-446. DOI: 10.1007/s12072-018-9877-7. View

Wong V, Wong G, Chu W, Chim A, Ong A, Yeung D . Hepatitis B virus infection and fatty liver in the general population. J Hepatol. 2011; 56(3):533-40. DOI: 10.1016/j.jhep.2011.09.013. View

Tong S, Revill P . Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016; 64(1 Suppl):S4-S16. PMC: 4834849. DOI: 10.1016/j.jhep.2016.01.027. View

Xia W, Shen Y, Xie H, Zheng S . Involvement of endoplasmic reticulum in hepatitis B virus replication. Virus Res. 2006; 121(2):116-21. DOI: 10.1016/j.virusres.2006.01.020. View

Patzer E, NAKAMURA G, Simonsen C, Levinson A, Brands R . Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol. 1986; 58(3):884-92. PMC: 252996. DOI: 10.1128/JVI.58.3.884-892.1986. View

Bruss V, Ganem D . The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A. 1991; 88(3):1059-63. PMC: 50954. DOI: 10.1073/pnas.88.3.1059. View

10.

Dorobantu C, Macovei A, Lazar C, Dwek R, Zitzmann N, Branza-Nichita N . Cholesterol depletion of hepatoma cells impairs hepatitis B virus envelopment by altering the topology of the large envelope protein. J Virol. 2011; 85(24):13373-83. PMC: 3233160. DOI: 10.1128/JVI.05423-11. View

11.

Lambert C, Prange R . Posttranslational N-glycosylation of the hepatitis B virus large envelope protein. Virol J. 2007; 4:45. PMC: 1891283. DOI: 10.1186/1743-422X-4-45. View

12.

Garcia P, Ou J, Rutter W, Walter P . Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol. 1988; 106(4):1093-104. PMC: 2114996. DOI: 10.1083/jcb.106.4.1093. View

13.

Wang J, Lee A, Ou J . Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment. J Virol. 1991; 65(9):5080-3. PMC: 248973. DOI: 10.1128/JVI.65.9.5080-5083.1991. View

14.

Lai E, Teodoro T, Volchuk A . Endoplasmic reticulum stress: signaling the unfolded protein response. Physiology (Bethesda). 2007; 22:193-201. DOI: 10.1152/physiol.00050.2006. View

15.

Walter P, Ron D . The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011; 334(6059):1081-6. DOI: 10.1126/science.1209038. View

16.

Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B . Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018; 69(4):927-947. DOI: 10.1016/j.jhep.2018.06.008. View

17.

Ma Y, Yu J, Chan H, Chen Y, Wang H, Chen Y . Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol Cell Proteomics. 2009; 8(11):2582-94. PMC: 2773723. DOI: 10.1074/mcp.M900180-MCP200. View

18.

Huang K, Lai Y, Lin C, Chang J . Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells. J Viral Hepat. 2009; 16(5):367-75. DOI: 10.1111/j.1365-2893.2009.01072.x. View

19.

BUCOLO G, David H . Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973; 19(5):476-82. View

20.

Wu L, Wang W, Zhang X, Zhao X, Yu G . Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitro. Carbohydr Polym. 2016; 143:139-48. DOI: 10.1016/j.carbpol.2016.01.065. View